Posts by Magali Bischof

Smart Protein Project | In search of a meat substitute   HES-SO Valais was selected to take part in the Smart Protein European project which aims at finding a substitute to meat. The valaisan Institute of Life Technologies will focus primarily on the quality control aspects. The Smart Protein project strives to find a sustainable nutrition…

Marc Thurner, founder of regenHU, Vivos Dental and mimix biotherapeutics joins Microcity as Stratup Program Manager   In October 2019, Marc Thurner joins the Microcity team to support the development of tech startups from the early stages to successful growth.   Marc Thurner has a strong experience in startup growth, thanks to his many experiences…

The rise of Life Sciences in the past 20 years by Entreprise Romande Everything you need to know   Discover Entreprise Romande‘s article, published as part of “Genève Sciences de la Vie“‘s 70th anniversary celebrations. BioAlps is happy to have taken part in this initiative. Western Switzerland is a fertile ground for the growth of…

How will the future of healthcare professions be affected by new technologies?   Agefi’s article provides insider knowledge regarding the main topics which will be discussed on Tuesday 29 October in Monthey during the BioAlps Networking Day 2019.   Speakers from BioAlps, Takeda and HEIG-VD share their perspectives regarding the shift in paradigm within life…

“The EPFL spin-off GTX Medical moves into the US market”   The Health Valley based startup, GTX Medical, which developed a solution to help patients with spinal cord injury walk again, is entering the US market. To do so, it has partnered with NeuroRecovery Technologies, a US-based company which developed a “transcutaneous stimulation therapy to…

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the main causes of deaths linked to breast cancer os metastasis. Research has shown that the most common location for metastasis, initiated with breast cancer, is the brain. EPFL scientists from the Swiss Institute of Experimental…

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019, Fresenius Kabi SwissBioSim, a Fresenius Kabi company, opened a new research and development center for biosimilars in Eysins, Switzerland. The R&D center, in which the healthcare company has invested about €15 million, will strengthen Fresenius…

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR) and the Fribourg Mental Health Network (RFSM)   This September, the Fribourg University welcomes 40 students for the opening of the Master of Medicine course. This 3 year course will prepare students towards the completion…

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care Abionic SA, a developer of disruptive nanotechnology based rapid diagnostic solutions, has announced on 13 September 2019 the successful completion of its multi-center observational study using Abionic’s novel point-of-care Pancreatic Stone Protein (PSP) sepsis test…

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used at EPFL to merge solutions from two different fields: neuroengineering and robotics. EPFL’s proof-of-concept has successfully been tested on 3 amputees and 7 healthy subjects. The AI technology behind EPFL’s project helps translate information received…